Market movement
In 2024, steroidal hormones, their derivatives and structural analogues: other than cortisone, hydrocortisone, prednisone (dehydrocortisone), prednisolone (dehydrohydrocortisone), halogenated derivatives of corticosteroidal hormones, oestrogen and progestogens trade exhibited significant decline, with global flows reaching $2,390,252,084 and a three-year compound annual growth rate of -7.2% (five-year: -10.6%). The all-time peak of $4,186,845,507 was recorded in 2019; the current level is 43% below that high-water mark.
Over the 30-year observation window (1995–2024), 52% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is decelerating (-5.3% acceleration).
The World Trade Flows Characterization classifies steroidal hormones, their derivatives and structural analogues: other than cortisone, hydrocortisone, prednisone (dehydrocortisone), prednisolone (dehydrohydrocortisone), halogenated derivatives of corticosteroidal hormones, oestrogen and progestogens as "One-way trade" in the high price range price segment, providing additional context for market positioning and competitive dynamics.
